The recent sharp rise in the share of diabetes treatment company D Medical Industries Ltd. (TASE:DMDC) has helped it to raise another Nis 12.9 million. On this occasion the money was raised following the realization of its Series 3 options.

This means that 99.5% of all the Series 3 options have now been realized including options of NIS 2.6 million, which were 20% of all options realized over the past day.

D Medical's management say that the financial target for realizing options has been allocated according to the company's efforts to introduce products onto new markets.

The company also plans dual listing in the US.

The company's share fell 2.89% today to NIS 1.38.

Published by Globes [online], Israel business news - www.globes-online.com - on April 6, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010